E, K., & N, H. (2024). Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer". International journal of urology : official journal of the Japanese Urological Association, 31(10), 1106. https://doi.org/10.1111/iju.15541
Chicago Style (17th ed.) CitationE, Kikuchi, and Hayakawa N. "Editorial Comment to "Efficacy and Safety of Dose-dense Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer"." International Journal of Urology : Official Journal of the Japanese Urological Association 31, no. 10 (2024): 1106. https://doi.org/10.1111/iju.15541.
MLA (9th ed.) CitationE, Kikuchi, and Hayakawa N. "Editorial Comment to "Efficacy and Safety of Dose-dense Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer"." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 31, no. 10, 2024, p. 1106, https://doi.org/10.1111/iju.15541.